Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials.

PubWeight™: 1.53‹?› | Rank: Top 4%

🔗 View Article (PMID 1416576)

Published in Ann Intern Med on November 01, 1992

Authors

D H Henry1, G N Beall, C A Benson, J Carey, L A Cone, L J Eron, M Fiala, M A Fischl, S J Gabin, M S Gottlieb

Author Affiliations

1: Graduate Hospital, Philadelphia, PA 19146.

Articles by these authors

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med (1997) 17.51

Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med (1981) 14.62

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med (1987) 13.84

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med (1987) 8.52

Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. N Engl J Med (1993) 8.49

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA (2000) 6.49

Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. JAMA (1997) 6.35

Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA. JAMA (1996) 5.29

Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17. Science (1987) 5.11

Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team. Ann Intern Med (1994) 4.74

Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. JAMA (1998) 4.61

Mycobacterial infections in AIDS patients, with an emphasis on the Mycobacterium avium complex. Rev Infect Dis (1987) 4.54

Pulmonary complications of the acquired immunodeficiency syndrome. Report of a National Heart, Lung, and Blood Institute workshop. N Engl J Med (1984) 4.46

Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N Engl J Med (1987) 4.38

Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med (1992) 4.30

Sequence-specific interaction of R17 coat protein with its ribonucleic acid binding site. Biochemistry (1983) 4.09

Evaluation of heterosexual partners, children, and household contacts of adults with AIDS. JAMA (1987) 3.99

Infection with HIV is associated with elevated IL-6 levels and production. J Immunol (1990) 3.89

The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group. AIDS (1999) 3.56

The acquired immunodeficiency syndrome. Ann Intern Med (1983) 3.49

Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT). Lancet (1988) 3.37

Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group. N Engl J Med (1995) 3.28

Tuberculosis, atypical mycobacteriosis, and the acquired immunodeficiency syndrome among Haitian and non-Haitian patients in south Florida. Ann Intern Med (1984) 3.25

Interaction of R17 coat protein with its RNA binding site for translational repression. J Biomol Struct Dyn (1983) 3.20

Gel retardation. Methods Enzymol (1991) 3.11

Epidemiology of cytomegalovirus infection after transplantation and immunosuppression. J Infect Dis (1975) 3.02

A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials Group. N Engl J Med (1995) 2.66

Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest (1995) 2.66

Tandem binding in crystals of a trp repressor/operator half-site complex. Nature (1993) 2.65

Acquired immune deficiency syndrome. Ocular manifestations. Ophthalmology (1983) 2.63

Megestrol acetate in patients with AIDS and cachexia. Ann Intern Med (1994) 2.62

Tuberculosis symposium: emerging problems and promise. J Infect Dis (1993) 2.55

Relation between sexual practices and T-cell subsets in homosexually active men. Lancet (1983) 2.46

Opportunistic infections and Kaposi's sarcoma among Haitians: evidence of a new acquired immunodeficiency state. Ann Intern Med (1983) 2.45

Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidine. Lancet (1987) 2.30

Interaction of R17 coat protein with synthetic variants of its ribonucleic acid binding site. Biochemistry (1983) 2.30

A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N Engl J Med (1995) 2.29

Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. N Engl J Med (1984) 2.26

Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci U S A (1996) 2.20

Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection. A phase I/II study. Ann Intern Med (1992) 2.19

Sequence of an HLA-DR alpha-chain cDNA clone and intron-exon organization of the corresponding gene. Nature (1982) 2.18

Interferon therapy for condylomata acuminata. N Engl J Med (1986) 2.16

Bronchial response to beta-adrenergic blockade. N Engl J Med (1966) 2.16

Enhancement of rhinovirus plaque formation in human heteroploid cell cultures by magnesium and calcium. J Bacteriol (1966) 2.15

A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J Immunol (1997) 2.15

Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial. J Clin Oncol (1998) 2.12

Immediate hypersensitivity reactions to beta-lactam antibiotics. Ann Intern Med (1987) 2.11

Kinetic and thermodynamic characterization of the R17 coat protein-ribonucleic acid interaction. Biochemistry (1983) 2.07

Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team. Ann Intern Med (1997) 2.06

Nocardiosis in 30 patients with advanced human immunodeficiency virus infection: clinical features and outcome. Clin Infect Dis (1994) 2.06

Treatment of cytomegalovirus retinopathy with ganciclovir. Ophthalmology (1987) 2.03

Mothers of infants with the acquired immunodeficiency syndrome. Evidence for both symptomatic and asymptomatic carriers. JAMA (1985) 2.02

[Conventional treatment of atrial fibrillation in the Czech Republic managed by outpatient cardiologists. Overview of diagnostic and treatment procedures, pharmacological treatment and hospitalisation]. Vnitr Lek (2008) 2.02

Lymphadenopathy associated virus infection of a blood donor--recipient pair with acquired immunodeficiency syndrome. Science (1984) 1.97

Arterial infections due to Listeria monocytogenes: report of four cases and review of world literature. Clin Infect Dis (1992) 1.94

Photosynthetic and phylogenetic primers for detection of anoxygenic phototrophs in natural environments. Appl Environ Microbiol (2001) 1.93

A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. AJR Am J Roentgenol (1997) 1.92

Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators. Ann Intern Med (1996) 1.92

Meat-wrapper's asthma. A new syndrome? JAMA (1973) 1.92

Immunological studies of homosexual men with immunodeficiency and Kaposi's sarcoma. Clin Immunol Immunopathol (1983) 1.91

Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis. Am J Pathol (1999) 1.86

Diabetes mellitus in twins. Diabetes (1968) 1.85

Sequences related to HLA-DR alpha chain on human chromosome 6: restriction enzyme polymorphism detected with DC alpha chain probes. Proc Natl Acad Sci U S A (1983) 1.85

CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Science (1996) 1.84

Contribution of meniscal extrusion and cartilage loss to joint space narrowing in osteoarthritis. Clin Radiol (1999) 1.82

Documentation of an AIDS virus infection in the United States in 1968. JAMA (1988) 1.81

Medicare costs in urban areas and the supply of primary care physicians. J Fam Pract (1996) 1.80

Glomerular lesions in the acquired immunodeficiency syndrome. Ann Intern Med (1984) 1.80

Susceptibility of herpesviruses to cytosine arabinoside: standardization of susceptibility test procedure and relative resistance of herpes simplex type 2 strains. Antimicrob Agents Chemother (1972) 1.79

Susceptibility of herpesviruses to three nucleoside analogues and their combinations and enhancement of the antiviral effect of acid pH. J Infect Dis (1974) 1.74

Genetic analysis of NF1: identification of close flanking markers on chromosome 17. Genomics (1987) 1.73

Hospitalization with vertebral fracture among the aged: a national population-based study, 1986-1989. Epidemiology (1992) 1.70

Immunologic aspects of the acquired immunodeficiency syndrome and male homosexuality. Med Clin North Am (1986) 1.69

Tightly linked markers for the neurofibromatosis type 1 gene. Genomics (1987) 1.68

Acquisition of antibody to hepatitis B antigen in three socioeconomically different medical populations. Lancet (1972) 1.67

Paternal origin of new mutations in von Recklinghausen neurofibromatosis. Nature (1990) 1.64

Effects of zidovudine therapy in minority and other subpopulations with early HIV infection. JAMA (1991) 1.62

Evaluating the role of CD4-lymphocyte counts as surrogate endpoints in human immunodeficiency virus clinical trials. Stat Med (1993) 1.62

Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A double-blind, placebo-controlled trial. N Engl J Med (1990) 1.61

Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group. Ann Neurol (1993) 1.61

Translation activates the paused transcription complex and restores transcription of the trp operon leader region. Proc Natl Acad Sci U S A (1985) 1.59

A comparison of the effectiveness of three regimens in the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients. Arch Intern Med (1992) 1.59

A study of the combined role of viruses, mycoplasmas and bacteria in adult pneumonia. Am J Med Sci (1969) 1.55

Solution structure of the DNA-binding domain and model for the complex of multifunctional hexameric arginine repressor with DNA. Nat Struct Biol (1997) 1.52

Use of whole blood methods in assessment of immune parameters in immunodeficiency states. Diagn Clin Immunol (1987) 1.51

Prevalence of measles antibodies in asymptomatic human immunodeficiency virus-infected adults. J Infect Dis (1991) 1.50

CD4 cell count as a surrogate endpoint in HIV clinical trials: a meta-analysis of studies of the AIDS Clinical Trials Group. AIDS (1998) 1.49

A comparison of the urological complications associated with long-term management of quadriplegics with and without chronic indwelling urinary catheters. J Urol (1992) 1.48

An index predicting relapse and need for hospitalization in patients with acute bronchial asthma. N Engl J Med (1981) 1.45

Outcome and cost analysis of scheduled versus emergency scleral buckling surgery. Ophthalmology (1992) 1.45

Intravenous antibiotic therapy in an outpatient setting. JAMA (1982) 1.43

Radioimmunoassay for measurement of triiodothyronine in human serum. J Clin Invest (1971) 1.43

Body composition in HIV-infected women. Nutrition (2001) 1.42

Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type 1 isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260). Antimicrob Agents Chemother (2000) 1.42

Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infection. Ann Intern Med (1993) 1.42

Two highly homologous putative DNA-binding proteins in yeast and E. coli. Trends Biochem Sci (1994) 1.41

The relationship between adjusted hospital mortality and the results of peer review. Health Serv Res (1993) 1.40

Regression of oral hairy leukoplakia during zidovudine therapy. Arch Intern Med (1988) 1.40